« A Federation of Independent Researchers? |
| More on the Federation of Independent Scientists: Journal Access »
April 13, 2012
AstraZeneca Cuts Again
I have word today that AstraZeneca has told the scientists at Reims that the French site will be closed by the end of the year, with oncology being "consolidated" in Alderley Park and the Boston area.
It's a good guess, given the patent situation the company's facing and the pipeline it has to deal with it, that this won't be the last announcement of its kind. . .
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- Merck's Aftermath
- Models and Reality
- Rewriting History at the Smithsonian?
- The FDA: Too Loose, Or Appropriately Brave?
- More Magic Methyls, Please
- Totaling Up a Job Search
- Humble Enzyme Dodges Spotlight
- Unraveling An Off-Rate